Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer

Oral Oncology

Volumn 46, Issue 10, 2010, Pages 767-772

  Weng, Chia Jui ^a   Chien, Ming Hsien ^b,c   Lin, Chiao Wen ^d   Chung, Tsung Te ^d,e   Zavras, Athanasios I ^f   Tsai, Chiung Man ^g   Chen, Mu Kuan ^d,h   Yang, Shun Fa ^d,i  

^a TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^f Columbia College of Dental Medicine ^*  (United States)

^g Chest Hospital   (Taiwan)

^h CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

ⁱ CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CC chemokine ligand 5; CC chemokine receptor 5; Oral cancer; Single nucleotide polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR5; RANTES;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

CASE-CONTROL STUDIES; CHEMOKINE CCL5; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, CCR5; RISK FACTORS;

EID: 77957340292     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.07.011     Document Type: Article

References (46)

1. S.F. Yang, W.E. Yang, H.R. Chang, S.C. Chu, and Y.S. Hsieh Luteolin induces apoptosis in oral squamous cancer cells J Dent Res 87 4 2008 401 406
2. F. Biolchini, G. Pollastri, S. Figurelli, and L. Chiarini Carcinogen metabolism, DNA damage repair and oral head and neck squamocellular carcinoma (HNSCC) Minerva Stomatol 54 7-8 2005 405 414
3. K.C. Lai, and T.C. Lee Genetic damage in cultured human keratinocytes stressed by long-term exposure to areca nut extracts Mutat Res 599 1-2 2006 66 75
4. N.S. Nagaraj, S. Beckers, J.K. Mensah, S. Waigel, N. Vigneswaran, and W. Zacharias Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells Toxicol Lett 165 2 2006 182 194
5. C.Y. Yen, S.Y. Liu, C.H. Chen, H.F. Tseng, L.Y. Chuang, and C.H. Yang Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan J Oral Pathol Med 37 5 2008 271 277
6. E. Vairaktaris, C. Yapijakis, Z. Serefoglou, S. Derka, S. Vassiliou, and E. Nkenke The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma Anticancer Res 28 1A 2008 309 314 (Pubitemid 351362918)
7. Y.H. Teng, T.H. Liu, H.C. Tseng, T.T. Chung, C.M. Yeh, and Y.C. Li Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer Head Neck 31 10 2009 1282 1288
8. A.B. Lowenfels, P. Maisonneuve, G. Cavallini, R.W. Ammann, P.G. Lankisch, and J.R. Andersen Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group N Engl J Med 328 20 1993 1433 1437
9. G. Dranoff Cytokines in cancer pathogenesis and cancer therapy Nat Rev Cancer 4 1 2004 11 22 (Pubitemid 38111131)
10. C.A. Wysocki, A. Panoskaltsis-Mortari, B.R. Blazar, and J.S. Serody Leukocyte migration and graft-versus-host disease Blood 105 11 2005 4191 4199
11. M. O'Hayre, C.L. Salanga, T.M. Handel, and S.J. Allen Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment Biochem J 409 3 2008 635 649
12. H. Kulbe, N.R. Levinson, F. Balkwill, and J.L. Wilson The chemokine network in cancer - much more than directing cell movement Int J Dev Biol 48 5-6 2004 489 496
13. T.J. Schall, K. Bacon, K.J. Toy, and D.V. Goeddel Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES Nature 347 6294 1990 669 671
14. S.J. Roth, M.W. Carr, and T.A. Springer C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes Eur J Immunol 25 12 1995 3482 3488
15. G. de la Rosa, N. Longo, J.L. Rodríguez-Fernández, A. Puig-Kroger, A. Pineda, and CorbíAL Migration of human blood dendritic cells across endothelial cell monolayers: Adhesion molecules and chemokines involved in subset-specific transmigration J Leukoc Biol 73 5 2003 639 649
16. A. Ben-Baruch Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators Semin Cancer Biol 16 1 2006 38 52
17. A.E. Karnoub, A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks, and G.W. Bell Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 7162 2007 557 563
18. N. Lapteva, and X.F. Huang CCL5 as an adjuvant for cancer immunotherapy Expert Opin Biol Ther 10 5 2010 725 733
19. G. Luboshits, S. Shina, O. Kaplan, S. Engelberg, D. Nass, and B. Lifshitz-Mercer Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma Cancer Res 59 18 1999 4681 4687
20. Y. Niwa, H. Akamatsu, H. Niwa, H. Sumi, Y. Ozaki, and A. Abe Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer Clin Cancer Res 7 2 2001 285 289
21. N. Yaal-Hahoshen, S. Shina, L. Leider-Trejo, I. Barnea, E.L. Shabtai, and E. Azenshtein The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients Clin Cancer Res 12 15 2006 4474 4480
22. L. Martin, C. Blanpain, P. Garnier, V. Wittamer, M. Parmentier, and C. Vita Structural and functional analysis of the RANTES-glycosaminoglycans interactions Biochemistry 40 21 2001 6303 6318
23. J.Y. Chuang, W.H. Yang, H.T. Chen, C.Y. Huang, T.W. Tan, and Y.T. Lin CCL5/CCR5 axis promotes the motility of human oral cancer cells J Cell Physiol 220 2 2009 418 426
24. M.K. Chen, H.T. Tsai, T.T. Chung, S.C. Su, T.Y. Kao, and H.C. Tseng Glutathione S-transferase P1 and alpha gene variants; role in susceptibility and tumor size development of oral cancer Head Neck 32 8 2010 1079 1087
25. H. Goecke, U. Forssmann, M. Uguccioni, H. Friess, J.R. Conejo-Garcia, and A. Zimmermann Macrophages infiltrating the tissue in chronic pancreatitis express the chemokine receptor CCR5 Surgery 128 5 2000 806 814
26. I. Esposito, M. Menicagli, N. Funel, F. Bergmann, U. Boggi, and F. Mosca Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma J Clin Pathol 57 6 2004 630 636
27. B. Farrow, Y. Sugiyama, A. Chen, E. Uffort, W. Nealon, and B. Mark Evers Inflammatory mechanisms contributing to pancreatic cancer development Ann Surg 239 6 2004 763 769 [discussion 769-771]
28. B.B. Aggarwal, R.V. Vijayalekshmi, and B. Sung Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe Clin Cancer Res 15 2 2009 425 430
29. G. McCormack, D. Moriarty, D.P. O'Donoghue, P.A. McCormick, K. Sheahan, and A.W. Baird Tissue cytokine and chemokine expression in inflammatory bowel disease Inflamm Res 50 10 2001 491 495
30. E. Azenshtein, G. Luboshits, S. Shina, E. Neumark, D. Shahbazian, and M. Weil The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity Cancer Res 62 4 2002 1093 1102
31. J.V. Stein, and C. Nombela-Arrieta Chemokine control of lymphocyte trafficking: a general overview Immunology 116 1 2005 1 12
32. S.C. Robinson, K.A. Scott, J.L. Wilson, R.G. Thompson, A.E. Proudfoot, and F.R. Balkwill A chemokine receptor antagonist inhibits experimental breast tumor growth Cancer Res 63 23 2003 8360 8365
33. P. An, G.W. Nelson, L. Wang, S. Donfield, J.J. Goedert, and J. Phair Modulating influence on HIV/AIDS by interacting CCL5 gene variants Proc Natl Acad Sci USA 99 15 2002 10002 10007
34. J. Lachheb, H. Chelbi, K. Hamzaoui, and A. Hamzaoui Association between rantes polymorphisms and asthma severity among Tunisian children Hum Immunol 68 8 2007 675 680
35. A. Zhernakova, B.Z. Alizadeh, P.H. Eerligh, P. Hanifi-Moghaddam, N.C. Schloot, and B. Diosdado Genetic variants of CCL5 are associated with serum CCL5 level and protection for type 1 diabetes Genes Immun 7 7 2006 544 549
36. E.J. Duell, D.P. Casella, R.D. Burk, K.T. Kelsey, and E.A. Holly Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma Cancer Epidemiol Biomarkers Prev 15 4 2006 726 731
37. J.C. Underwood Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review Br J Cancer 30 6 1974 538 548
38. C.M. Balch, L.B. Riley, Y.J. Bae, M.A. Salmeron, C.D. Platsoucas, and A. von Eschenbach Patterns of human tumorinfiltrating lymphocytes in 120 human cancers Arch Surg 125 2 1990 200 205
39. A. Kawata, Y. Une, M. Hosokawa, J. Uchino, and H. Kobayashi Tumorinfiltrating lymphocytes and prognosis of hepatocellular carcinoma Jpn J Clin Oncol 22 4 1992 256 263
40. Y. Wada, O. Nakashima, R. Kutami, O. Yamamoto, and M. Kojiro Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration Hepatology 27 2 1998 407 414
41. M. Baggiolini Chemokines and leukocyte traffic Nature 392 6676 1998 565 568
42. B. Bottazzi, N. Polentarutti, R. Acero, A. Balsari, D. Boraschi, and P. Ghezzi Regulation of the macrophage content of neoplasms by chemoattractants Science 220 4593 1983 210 221
43. R.P.M. Negus, G.W.H. Stamp, J. Hadley, and F.R. Balkwill Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines Am J Pathol 150 5 1997 1723 1734
44. S. Sharma, M. Stolina, L. Zhu, Y. Lin, R. Batra, and M. Huang Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma Cancer Res 61 17 2001 6406 6412
45. J.J. Mule, M. Custer, B. Averbook, J.C. Yang, J.S. Weber, and D.V. Goeddel RANTES secretion by genemodified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations Hum Gene Ther 7 13 1996 1545 1553
46. D.A. Arenberg, M.P. Keane, B. DiGiovine, S.L. Kunkel, S.R.B. Strom, and M.D. Burdick Macrophage infiltration in human non-small-cell lung cancer: the role of C-C chemokines Cancer Immunol Immunother 49 2 2000 63 70